Close Menu

In planning her upcoming semester, DrdrA wonders about her institution's priorities. "Individual research program first, teaching second. Right? But the problem with this is that this is not how the institution [sees] these responsibilities — or it is, at least, not how they talk about them," she writes, adding that she has sat in plenty of meetings on revamping curriculum and the needs of students but none on how to manage and run a strong research group.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.